Caption Management, LLC Cassava Sciences Inc Put Options Transaction History

Caption Management, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$17.22 - $38.47 $621,642 - $1.39 Million	-36,100 Reduced 24.15%	113,400 $3.19 Million
Q1 2022 May 13, 2022	BUY	$32.6 - $53.05 $1.61 Million - $2.63 Million	49,500 Added 49.5%	149,500 $5.55 Million
Q2 2021 Aug 16, 2021	BUY	$32.15 - $89.72 $3.22 Million - $8.97 Million	100,000 New	100,000 $8.54 Million

196

13.8M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $101M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.